AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16402746 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface feature variation (same timbre or different timbre)
Number of subjects: 0
Study 16402746 — intervention group
Group type: EXPERIMENTAL
Intervention: Encoding task (semantic or nonsemantic)
Number of subjects: 0
Study 12359039 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazabemide 100 mg/day
Number of subjects: 330
Study 12359039 — intervention group
Group type: EXPERIMENTAL
Intervention: Lazabemide 200 mg/day
Number of subjects: 330
Study 12359039 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 330
Study 10427455 — intervention group
Group type: EXPERIMENTAL
Intervention: Intercostal blocks (ICB) with 5 ml 0.5% bupivacaine at the end of surgery and 6 h later
Number of subjects: 36
Study 10427455 — intervention group
Group type: EXPERIMENTAL
Intervention: Interpleural analgesia (IPA) with 20 ml 0.25% bupivacaine applied every 4 h using a catheter
Number of subjects: 36
Study 10427455 — intervention group
Group type: COMPARATOR
Intervention: IV-opioid-PCA with piritamide (control group)
Number of subjects: 36
Study 8789361 — intervention group
Group type: EXPERIMENTAL
Intervention: Speciality Care Workers (SCW)
Number of subjects: 947
Study 8789361 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary Care Workers (PCW)
Number of subjects: 947
Study 8789361 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Satisfaction
Number of subjects: 947
Study 2372459 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus enhanced scanning
Number of subjects: 53
Study 2372459 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed scanning
Number of subjects: 53
Study 2372459 — intervention group
Group type: COMPARATOR
Intervention: Non-enhanced scanning
Number of subjects: 53
Study 6101631 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 units/kg of factor VIII
Number of subjects: 0
Study 6101631 — intervention group
Group type: EXPERIMENTAL
Intervention: 14 units/kg of factor VIII
Number of subjects: 0
Study 6101631 — intervention group
Group type: EXPERIMENTAL
Intervention: 28 units/kg of factor VIII
Number of subjects: 0
Study 6101631 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 29852877 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and Root Planing (SRP) followed by subgingival application of curcumin gel
Number of subjects: 30
Study 29852877 — intervention group
Group type: COMPARATOR
Intervention: Scaling and Root Planing (SRP) alone
Number of subjects: 30
Study 28255797 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetate-buffered balanced crystalloid
Number of subjects: 150
Study 28255797 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline
Number of subjects: 150
Study 24999785 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine Fe (n 2184; 60 mg ferrous sulfate plus 400 μg folic acid daily throughout pregnancy)
Number of subjects: 4326
Study 24999785 — intervention group
Group type: COMPARATOR
Intervention: Selective Fe (n 2142; screening and treatment for anaemia and daily intake of 1 mg folic acid)
Number of subjects: 4326
Study 22933442 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard model representing the current MetS definition
Number of subjects: 1928
Study 22933442 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard model excluding blood pressure
Number of subjects: 1928
Study 22933442 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard model extended with hsCRP
Number of subjects: 1928
Study 22933442 — intervention group
Group type: COMPARATOR
Intervention: Standard model
Number of subjects: 1928
Study 21564444 — intervention group
Group type: EXPERIMENTAL
Intervention: botulinum toxin-A (100 U Botox)
Number of subjects: 23
Study 21564444 — intervention group
Group type: COMPARATOR
Intervention: saline (placebo)
Number of subjects: 23
Study 18473021 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral‐B Exceed
Number of subjects: 48
Study 18473021 — intervention group
Group type: COMPARATOR
Intervention: Asian Colgate 360 masculine
Number of subjects: 48
Study 16046439 — intervention group
Group type: COMPARATOR
Intervention: North America
Number of subjects: 1484
Study 16046439 — intervention group
Group type: COMPARATOR
Intervention: North West Europe
Number of subjects: 1484
Study 16046439 — intervention group
Group type: COMPARATOR
Intervention: Scandinavia
Number of subjects: 1484
Study 15368824 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls prevention service intervention (falls risk assessment and evidence-based prescription to GP)
Number of subjects: 140
Study 15368824 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 140
Study 10855462 — intervention group
Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 18
Study 10855462 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 18
Study 9084819 — intervention group
Group type: EXPERIMENTAL
Intervention: E.P.D. (Enzyme Potentiated Desensibilization)
Number of subjects: 40
Study 9084819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 8256898 — intervention group
Group type: EXPERIMENTAL
Intervention: 750 mg ciprofloxacin daily for 7 days
Number of subjects: 30
Study 8256898 — intervention group
Group type: COMPARATOR
Intervention: 300 ng isoniazid daily for 7 days
Number of subjects: 30
Study 8256898 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (C), isoniazid (H), rifampin (R) - regimen HRC
Number of subjects: 30
Study 8256898 — intervention group
Group type: COMPARATOR
Intervention: Rifampin (R), isoniazid (H), pyrazinamide (Z), ethambutol (E) - regimen HRZE
Number of subjects: 30
Study 2869208 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrocoagulation (small bipolar probe)
Number of subjects: 204
Study 2869208 — intervention group
Group type: COMPARATOR
Intervention: Not treated with electrocoagulation (control group)
Number of subjects: 204
Study 27585399 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic soft contact lens (TSCL)
Number of subjects: 15
Study 27585399 — intervention group
Group type: COMPARATOR
Intervention: No therapeutic soft contact lens (Control)
Number of subjects: 15
Study 27815186 — intervention group
Group type: EXPERIMENTAL
Intervention: Strabismus surgery in contact lens group (CL)
Number of subjects: 114
Study 27815186 — intervention group
Group type: EXPERIMENTAL
Intervention: Strabismus surgery in intraocular lens group (IOL)
Number of subjects: 114
Study 27815186 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative distance alignment after strabismus surgery
Number of subjects: 114
Study 27815186 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity with strabismus surgery
Number of subjects: 114
Study 27815186 — intervention group
Group type: EXPERIMENTAL
Intervention: Age at cataract surgery and strabismus surgery frequency
Number of subjects: 114
Study 25516481 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 80
Study 25516481 — intervention group
Group type: COMPARATOR
Intervention: Sham Moxibustion (Control)
Number of subjects: 80
Study 21095634 — intervention group
Group type: EXPERIMENTAL
Intervention: Calming music and standard care
Number of subjects: 68
Study 21095634 — intervention group
Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 68
Study 20338978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural group intervention with pedometer, 5 sessions over 12 weeks, booster session after 22 weeks
Number of subjects: 41
Study 20338978 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural group intervention with pedometer
Number of subjects: 41
Study 20338978 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 41
Study 19001206 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation 1200 mg/d
Number of subjects: 323
Study 19001206 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation 600 mg/d
Number of subjects: 323
Study 19001206 — intervention group
Group type: COMPARATOR
Intervention: Calcium supplementation
Number of subjects: 323
Study 16308009 — intervention group
Group type: EXPERIMENTAL
Intervention: Off‐pump coronary artery bypass grafting plus autologous stem cell transplantation (CD34+)
Number of subjects: 20
Study 16308009 — intervention group
Group type: COMPARATOR
Intervention: Off‐pump coronary artery bypass grafting
Number of subjects: 20
Study 12869120 — intervention group
Group type: EXPERIMENTAL
Intervention: PCR-based genotyping for blood group antigens (Rh, Kell, Duffy, Kidd)
Number of subjects: 100
Study 10553845 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 40
Study 10553845 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoflurane anesthesia
Number of subjects: 40
Study 10553845 — intervention group
Group type: COMPARATOR
Intervention: Both anesthetics
Number of subjects: 40
Study 8875693 — intervention group
Group type: EXPERIMENTAL
Intervention: diatrizoate
Number of subjects: 34
Study 8875693 — intervention group
Group type: COMPARATOR
Intervention: iopromide
Number of subjects: 34
Study 1650526 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiation therapy (HFX) at 69.6 Gy
Number of subjects: 120
Study 1650526 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Stage II and III HFX 69.6 Gy
Number of subjects: 120
Study 1650526 — intervention group
Group type: COMPARATOR
Intervention: Standard once-a-day irradiation (Control)
Number of subjects: 120
Study 6922455 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral instructions (behavioral control)
Number of subjects: 40
Study 6922455 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory information (cognitive control)
Number of subjects: 40
Study 6922455 — intervention group
Group type: EXPERIMENTAL
Intervention: Both behavioral instructions and sensory information
Number of subjects: 40
Study 6922455 — intervention group
Group type: COMPARATOR
Intervention: General information
Number of subjects: 40
Study 31308262 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine with clonidine 75 µg
Number of subjects: 160
Study 31308262 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine with dexamethasone 8 mg
Number of subjects: 160
Study 31308262 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine with buprenorphine 300 µg
Number of subjects: 160
Study 31308262 — intervention group
Group type: COMPARATOR
Intervention: ropivacaine alone (control)
Number of subjects: 160
Study 29032393 — intervention group
Group type: EXPERIMENTAL
Intervention: RSH‐VHL (repeated-sprint exercise with voluntary hypoventilation)
Number of subjects: 9
Study 29032393 — intervention group
Group type: EXPERIMENTAL
Intervention: RSH‐VHL
Number of subjects: 9
Study 29032393 — intervention group
Group type: COMPARATOR
Intervention: RSN (repeated-sprint exercise with normal breathing)
Number of subjects: 9
Study 26720443 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-9054 30.0 μg/mL
Number of subjects: 48
Study 26720443 — intervention group
Group type: EXPERIMENTAL
Intervention: ONO-9054 (0.3, 1.0, 3.0, 10.0, 20.0, or 30.0 μg/mL)
Number of subjects: 48
Study 26720443 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 25453117 — intervention group
Group type: EXPERIMENTAL
Intervention: Repositioning suture of the erector spinae muscle
Number of subjects: 393
Study 25453117 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture of the erector spinae muscle
Number of subjects: 393
Study 22957320 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonography (US)
Number of subjects: 104
Study 22957320 — intervention group
Group type: COMPARATOR
Intervention: No Ultrasonography (Control)
Number of subjects: 104
Study 19740585 — intervention group
Group type: EXPERIMENTAL
Intervention: Classic laryngeal mask airway (LMA)
Number of subjects: 100
Study 19740585 — intervention group
Group type: COMPARATOR
Intervention: Laerdal Pocket Facemask (LPFM)
Number of subjects: 100
Study 17694727 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 46
Study 17694727 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental oxygen
Number of subjects: 46
Study 17694727 — intervention group
Group type: COMPARATOR
Intervention: Placebo-CPAP
Number of subjects: 46
Study 15957626 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-propofol
Number of subjects: 50
Study 15957626 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl-midazolam
Number of subjects: 50
Study 15957626 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 11791958 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin (500 mg for adults, 10 mg/kg for children) for 5 days followed by 2 days of placebo (A5)
Number of subjects: 227
Study 11791958 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin (500 mg for adults, 10 mg/kg for children) for 7 days (A7)
Number of subjects: 227
Study 11791958 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemisinin (A5)
Number of subjects: 227
Study 9888619 — intervention group
Group type: EXPERIMENTAL
Intervention: Metergoline (serotonin antagonist)
Number of subjects: 24
Study 9888619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 9888619 — intervention group
Group type: EXPERIMENTAL
Intervention: Metergoline
Number of subjects: 24
Study 7711686 — intervention group
Group type: EXPERIMENTAL
Intervention: Pen-based electronic questionnaires
Number of subjects: 46
Study 7711686 — intervention group
Group type: COMPARATOR
Intervention: Conventional paper questionnaires
Number of subjects: 46
Study 2547216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mopidamol (2 x mg i.v. daily perioperatively, 3 x 500 mg orally postoperatively)
Number of subjects: 270
Study 2547216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 2547216 — intervention group
Group type: EXPERIMENTAL
Intervention: Mopidamol
Number of subjects: 270
Study 2547216 — intervention group
Group type: COMPARATOR
Intervention: Mopidamol and Placebo
Number of subjects: 270
Study 1101386 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 36
Study 1101386 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 36
Study 1101386 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 30153268 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol
Number of subjects: 801
Study 30153268 — intervention group
Group type: COMPARATOR
Intervention: No beta-blocker
Number of subjects: 801
Study 27549212 — intervention group
Group type: EXPERIMENTAL
Intervention: i-gel
Number of subjects: 150
Study 27549212 — intervention group
Group type: COMPARATOR
Intervention: LMA Supreme
Number of subjects: 150
Study 27549212 — intervention group
Group type: COMPARATOR
Intervention: LMA ProSeal
Number of subjects: 150
Study 23879735 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with high implicit power motive who exerted power over another person in Study 1
Number of subjects: 141
Study 23879735 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with high implicit achievement motive who mastered a frustrating sensorimotor task in Study 2
Number of subjects: 141
Study 23879735 — intervention group
Group type: COMPARATOR
Intervention: Control conditions in both studies
Number of subjects: 141
Study 22744746 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention (patient education, therapeutic monitoring, communication with primary care providers)
Number of subjects: 281
Study 22744746 — intervention group
Group type: COMPARATOR
Intervention: Usual care (regular follow-up with primary care providers)
Number of subjects: 281
Study 22744746 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacist intervention
Number of subjects: 281
Study 19629055 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage meal (25% of estimated energy need)
Number of subjects: 43
Study 19629055 — intervention group
Group type: COMPARATOR
Intervention: Solid meal (25% of estimated energy need)
Number of subjects: 43
Study 19629055 — intervention group
Group type: EXPERIMENTAL
Intervention: Beverage meal (12.5% of estimated energy need)
Number of subjects: 43
Study 19629055 — intervention group
Group type: COMPARATOR
Intervention: Solid meal (12.5% of estimated energy need)
Number of subjects: 43
Study 18337267 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous BIV pacing (BIV 0)
Number of subjects: 69
Study 18337267 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimized BIV pacing (with individually optimized VV interval)
Number of subjects: 69
Study 18337267 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-chamber pacing (LV or RV)
Number of subjects: 69
Study 15864634 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory impedance threshold device (ITD) set to open at 0.7 kPa (7-cm H2O)
Number of subjects: 18
Study 15864634 — intervention group
Group type: COMPARATOR
Intervention: Sham device
Number of subjects: 18
Study 11306850 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole 2% shampoo
Number of subjects: 66
Study 11306850 — intervention group
Group type: COMPARATOR
Intervention: Ketoconazole 1% shampoo
Number of subjects: 66
Study 9312365 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygous factor V Leiden mutation
Number of subjects: 22
Study 9312365 — intervention group
Group type: COMPARATOR
Intervention: Heterozygous factor V Leiden mutation
Number of subjects: 22
Study 8047747 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrogate endpoints
Number of subjects: 0
Study 8047747 — intervention group
Group type: EXPERIMENTAL
Intervention: Auxiliary endpoints
Number of subjects: 0
Study 3148458 — intervention group
Group type: EXPERIMENTAL
Intervention: Vamin
Number of subjects: 32
Study 3148458 — intervention group
Group type: EXPERIMENTAL
Intervention: Paedmin
Number of subjects: 32
Study 2102668 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily regimen
Number of subjects: 105
Study 2102668 — intervention group
Group type: COMPARATOR
Intervention: Three-time daily regimen
Number of subjects: 105
Study 30845819 — intervention group
Group type: EXPERIMENTAL
Intervention: Executive training
Number of subjects: 0
Study 30845819 — intervention group
Group type: COMPARATOR
Intervention: Perceptual training
Number of subjects: 0
Study 27699880 — intervention group
Group type: COMPARATOR
Intervention: UVB nb (311 nm) phototherapy alone
Number of subjects: 53
Study 27699880 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of UVB nb and UVA (320‐400 nm) phototherapy
Number of subjects: 53
Study 25902810 — intervention group
Group type: EXPERIMENTAL
Intervention: Pitolisant (BF2.649)
Number of subjects: 95
Study 25902810 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 95
Study 25902810 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study 23283505 — intervention group
Group type: EXPERIMENTAL
Intervention: Maltodextrins with glutamine (group 1)
Number of subjects: 24
Study 23283505 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein powder (group 2)
Number of subjects: 24
Study 23283505 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrins alone (control)
Number of subjects: 24
Study 21332272 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B sulfate, neomycin sulfate and gramicidin (PS) ear drops, thrice daily for 10 ± 2 days
Number of subjects: 244
Study 21332272 — intervention group
Group type: COMPARATOR
Intervention: Glycerol ear drops, thrice daily for 10 ± 2 days
Number of subjects: 244
Study 21332272 — intervention group
Group type: EXPERIMENTAL
Intervention: Polymyxin B sulfate, neomycin sulfate and gramicidin (PS) ear drops
Number of subjects: 244
Study 18676131 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 0
Study 18676131 — intervention group
Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 0
Study 17286197 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet administered CHQ-CF questionnaire
Number of subjects: 1071
Study 17286197 — intervention group
Group type: COMPARATOR
Intervention: Paper administered CHQ-CF questionnaire
Number of subjects: 1071
Study 17286197 — intervention group
Group type: EXPERIMENTAL
Intervention: Both internet and paper administration
Number of subjects: 1071
Study 14749753 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit juices (1 l daily for 16 weeks)
Number of subjects: 41
Study 14749753 — intervention group
Group type: COMPARATOR
Intervention: Fruit-vegetable-concentrate (30 ml daily for 16 weeks)
Number of subjects: 41
Study 11843990 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 208
Study 11843990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study 9794841 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclizumab (humanized monoclonal antibodies against the IL-2 receptor) added to standard cyclosporin-based immunosuppression
Number of subjects: 0
Study 9794841 — intervention group
Group type: COMPARATOR
Intervention: Standard cyclosporin-based immunosuppression
Number of subjects: 0
Study 7529038 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (high-dose regimen)
Number of subjects: 69
Study 7529038 — intervention group
Group type: COMPARATOR
Intervention: No aprotinin (control group)
Number of subjects: 69
Study 2908433 — intervention group
Group type: EXPERIMENTAL
Intervention: Epanolol (100 mg twice daily for 4 weeks)
Number of subjects: 6
Study 2908433 — intervention group
Group type: COMPARATOR
Intervention: Atenolol (100 mg once daily)
Number of subjects: 6
Study 30790639 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant CSL2 (Lys204Arg)
Number of subjects: 48
Study 30790639 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant CSL3 (Lys203Arg/Lys204Arg)
Number of subjects: 48
Study 30790639 — intervention group
Group type: COMPARATOR
Intervention: Wild-type HheC
Number of subjects: 48
Study 27669373 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% sodium bicarbonate saline solution for oral care
Number of subjects: 104
Study 27669373 — intervention group
Group type: COMPARATOR
Intervention: Control group (no additional treatment)
Number of subjects: 104
Study 26334338 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation learning experience taught by senior-level students
Number of subjects: 60
Study 26334338 — intervention group
Group type: COMPARATOR
Intervention: Simulation learning experience taught by nursing faculty
Number of subjects: 60
Study 23563246 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 426
Study 23563246 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive performance (ADAS-cog/MCI test)
Number of subjects: 426